Ozempic and Wegovy, Novo Nordisk’s GLP-1 drugs that treat diabetes and obesity, are on the list. Astellas Pharma’s prostate cancer drug, Xtandi, is also on the list — alongside AstraZeneca’s cancer ...

The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, which includes Ozempic.

Randomization was through arbitrarily allocation to one of the two treatment groups based on a computer-generated random list (GraphPad ... regular inhaled medication for COPD, such as short ...

The list for the next round of medicines that ... reckons a chronic obstructive pulmonary disease (COPD) drug will be included – and is preparing to contribute to the process.

For a detailed overview of this drug, check out this in-depth Namenda article. If you have questions about drug interactions that may affect you, talk with your doctor or pharmacist. The table ...

A 75-year-old woman with a history of type 2 diabetes mellitus, resistant hypertension, obesity, and chronic obstructive pulmonary disease (COPD ... New cardiometabolic drugs such as glucagon ...

The Centers for Medicare and Medicaid Services (CMS) had until Feb. 1 to release the list ... by these drugs include diabetes, cancer, chronic obstructive pulmonary disease (COPD) and schizophrenia.

Background The Global Obstructive Lung Disease (GOLD) 2011 revision recommends the multidimensional assessment of COPD including comorbidities ... confirmed by either reviewing the patient's ...

If you have questions about drug interactions that may affect you, talk with your doctor or pharmacist. The table below lists ... as contraindications. The list below includes contraindications ...

Regeneron shares have been in a bearish trend since August, losing over one third of their value. Read why I am initiating ...